Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Duffy

Showing results (31-40 of 600) with videos related to

Pageof 60
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2022
Modeling Multicancer ScreeningStephen W Duffy, Peter Sasieni
Journal of Medical Screening|September 24, 2025
Comments on "Effects of COVID-19 pandemic on breast cancer screening" by Huang et al. https://doi.org/10.1177/09691413251338456Kathie Binysh, Stephen W Duffy
British Journal of Cancer|July 1, 1988
Risk of breast cancer in relation to reproductive factors in DenmarkM Ewertz, S W Duffy
Journal of Chronic Diseases|January 1, 1987
Screening for breast cancerS W Duffy, L Tabar
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Evaluation of service screening mammography in practice: the impact on breast cancer mortalityR Gabe, S W Duffy
Lancet (London, England)|March 7, 2000
Screening mammography re-evaluatedS W Duffy, L Tabar
International Journal of Epidemiology|December 1, 1991
Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986)E Paci, S W Duffy
Lancet (London, England)|October 29, 1994
Breast cancer: have we missed the forest because of the tree?S W Duffy, L Tabar
Breast Cancer Research : BCR|May 18, 2013
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeStephen W Duffy, Dharmishta Parmar
AORN Journal|October 3, 1998
Power perceived is power achievedW Duffy, M C Duffy
Pageof 60

Showing results (31-40 of 600) with videos related to

Sort By:
Pageof 60
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2022
Modeling Multicancer ScreeningStephen W Duffy, Peter Sasieni
Journal of Medical Screening|September 24, 2025
Comments on "Effects of COVID-19 pandemic on breast cancer screening" by Huang et al. https://doi.org/10.1177/09691413251338456Kathie Binysh, Stephen W Duffy
British Journal of Cancer|July 1, 1988
Risk of breast cancer in relation to reproductive factors in DenmarkM Ewertz, S W Duffy
Journal of Chronic Diseases|January 1, 1987
Screening for breast cancerS W Duffy, L Tabar
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Evaluation of service screening mammography in practice: the impact on breast cancer mortalityR Gabe, S W Duffy
Lancet (London, England)|March 7, 2000
Screening mammography re-evaluatedS W Duffy, L Tabar
International Journal of Epidemiology|December 1, 1991
Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986)E Paci, S W Duffy
Lancet (London, England)|October 29, 1994
Breast cancer: have we missed the forest because of the tree?S W Duffy, L Tabar
Breast Cancer Research : BCR|May 18, 2013
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeStephen W Duffy, Dharmishta Parmar
AORN Journal|October 3, 1998
Power perceived is power achievedW Duffy, M C Duffy
Pageof 60